Thyroid hormone changes cardiomyocyte shape and geometry via ERK signaling pathway: Potential therapeutic implications in reversing cardiac remodeling?

Molecular and Cellular Biochemistry

Volumn 297, Issue 1-2, 2007, Pages 65-72

  Pantos, C ^a   Xinaris, Christodoulos ^a   Mourouzis, Iordanis ^a   Malliopoulou, Vassiliki ^a   Kardami, Elissavet ^b   Cokkinos, Dennis V ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF MANITOBA   (Canada)

^c ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Cardiac myocytes; Cardiacre modeling; Cell signaling; ERK; Thyroid hormone

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; LIOTHYRONINE; MAJOR HISTOCOMPATIBILITY ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; THYROID HORMONE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL SHAPE; CELL SIZE; CONTROLLED STUDY; DRUG POTENCY; GEOMETRY; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HORMONE ACTION; NEWBORN; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; CELL SHAPE; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLAVONOIDS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCYTES, CARDIAC; MYOSINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RATS; TRIIODOTHYRONINE; VENTRICULAR REMODELING;

EID: 33947423265     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9323-3     Document Type: Article

References (27)

1. Kinugawa K, Yonekura K, Ribeiro RC, Eto Y, Aoyagi T, Baxter JD, Camacho SA, Bristow MR, Long CS, Simpson PC (2001) Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ Res 89(7): 591-598
2. Pantos C, Mourouzis I, Saranteas T, Paizis I, Xinaris C, Malliopoulou V, Cokkinos DV (2005) Thyroid hormone receptors alpha1 and beta1 are downregulated in the post-infarcted rat heart: Consequences on the response to ischemia-reperfusion. Bas Res Cardiol 100(5): 422-432
3. Pingitore A, Landi P, Taddei CM, Ripoli A, L'Abatte A, Iervasi G (2005) Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med 118: 132-136
4. Morkin E, Ladenson P, Goldman S, Adamson C (2004) Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: Past, present and future prospects. J Mol Cell Cardiol 37: 1137-1146
5. Ojamaa K, Kenessey A, Shenoy R, Klein I (2000) Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat. Am J Physiol 279(6): E1319-E1324
6. Pantos C, Malliopoulou V, Varonos D, Cokkinos DV (2004) Thyroid hormone and phenotypes of cardioprotection. Basic Res Cardiol 99: 101-120
7. Thomas TA, Kuzman JA, Anderson BE, Andersen SM, Schlenker EH, Holder MS, Gerdes AM (2005) Thyroid hormones induce unique and potentially beneficial changes in cardiac myocyte shape in hypertensive rats near heart failure. Am J Physiol 288(5): H2118-H2122
8. Gerdes AM (2002) Cardiac myocyte remodeling in hypertrophy and progression to failure. J Card Fail 8(6 Suppl): S264-S268
9. Milani RV, Lavie CJ, Mehra MR, Ventura HO, Kurtz JD, Messerli FH (2006) Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol 97(7):959-963
10. Douglas PS, Morrow R, Ioli A, Reichek N (1989) Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. JACC 13(2):311-315
11. Pantos C, Mourouzis I, Malliopoulou V, Paizis I, Tzeis S, Moraitis P, Sfakianoudis K, Varonos DD, Cokkinos DV (2005) Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: A possible involvement of thyroid hormone receptor alpha1. Thyroid 15(1): 16-23
12. Detillieux KA, Meij JT, Kardami E, Cattini PA (1999) alpha1-Adrenergic stimulation of FGF-2 promoter in cardiac myocytes and in adult transgenic mouse hearts. Am J Physiol 276(3 Pt 2): H826-H833
13. Gosteli-Peter MA, Harder BA, Eppenberger HM, Zapf J, Schaub MC (1996) Triiodothyronine induces over-expression of alpha-smooth muscle actin, restricts myofibrillar expansion and is permissive for the action of basic FGF and IGF-I in adult rat cardiomyocytes. J Clin Invest 98(8): 1737-1744
14. Pantos C, Malliopoulou V, Mourouzis I, Moraitis P, Tzeis S, Thempeyioti A, Paizis I, Cokkinos AD, Carageorgiou H, Varonos D, Cokkinos DV (2003) Involvement of p38 MAPK and JNK in the heat stress induced cardioprotection. Basic Res Cardiol 98: 158-164
15. Pantos C, Malliopoulou V, Paizis I, Moraitis P, Mourouzis I, Tzeis S, Karamanoli E, Cokkinos DD, Carageorgiou H, Varonos D, Cokkinos DV (2003) Thyroid hormone and cardioprotection; study of p38 MAPK and JNKs during ischemia and at reperfusion in isolated rat heart. Mol Cell Biochem 242: 173-180
16. Lai J, Jin H, Yang R, Winer J, Li W, Yen R, King KL, Zeigler F, Ko A, Cheng J, Bunting S, Paoni NF (1996) Prostaglandin F2 alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo. Am J Physiol 271(6 Pt 2): H2197-H2208
17. Reiser PJ, Kline WO (1998) Electrophoretic separation and quantitation of cardiac myosin heavy chain isoforms in eight mammalian species. Am J Physiol 274(3 Pt 2): H1048-H1053
18. Xinaris C, Mourouzis I, Carageorgiou X, Pantos C, Cokkinos DV (2006) Differential activation of stress kinase sigmaling by phenylephrine and thyroid hormone in neonatal cardiomyocytes. J Mol Cell Cardiol 40(6): 217 (Abstract)
19. Okoshi MP, Yan X, Okoshi K, Nakayama M, Schuldt AJ, O'Connell TD, Simpson PC, Lorell BH (2004) Aldosterone directly stimulates cardiac myocyte hypertrophy. J Card Fail 10(6): 511-518
20. Xinaris C, Mourouzis I, Pantos C, Cokkinos DV (2006) Thyroid hormone promotes cardiac myocyte plasticity via activation of stress kinase signalling. J Mol Cell Cardiol 40(6): 218, (Abstract)
21. Kenessey A, Ojamaa K: Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J Biol Chem, http://www.jbc.org/cgi/doi/10.1074/jbc.M512671200 (May 2006)
22. Davis FB, Mousa SA, O'Connor L, Mohamed S, Lin HY,Cao JH, Davis PJ (2004) Proangiogenic action of thyroid hormone is fibroblast factor- dependent and is initiated at the cell surface. Circ Res 94: 1500-1506
23. Rubinfeld H, Seger R (2005) The ERK cascade: A prototype of MAPK signaling. Mol Biotechnol 31(2): 151-174(Review)
24. Yellon DM, Opie LH (2006) Postconditioning for protection of the infarcting heart. Lancet 367(9509): 456-458
25. Pantos C, Malliopoulou V, Mourouzis I, Karamanoli E, Paizis I, Steimberg N, Varonos D, Cokkinos DV (2002) Long-term thyroxine administration protects the heart in a similar pattern as ischemic preconditioning. Thyroid 12: 325-329
26. Zinman T, Shneyvays V, Tribulova N, Manoach M, Shainberg A (2006) Acute, nongenomic effect of thyroid hormones in preventing calcium overload in newborn rat cardiocytes. J Cell Physiol 207(1): 220-31
27. Pantos C, Malliopoulou V, Mourouzis I, Karamanoli E, Moraitis P, Tzeis S, Paizis I, Carageorgiou H, Varonos D, Cokkinos DV (2003) Thyroxine pretreatment increases basal myocardial HSP27 expression and accelerates translocation and phosphorylation of this protein upon ischemia. Eur J Pharmacol 478: 53-60